Effects of ECA on Quality of Life in Head and Neck Cancer Patients Suffering From Cetuximab-induced Rhagades
Clinical trial NCT01693159 · UNKNOWN
Trial details
- NCT number
- NCT01693159
- Sponsor
- National Center for Tumor Diseases, Heidelberg
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2018-07-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.